French health and biotechnology

Preparing today for tomorrow's healthcare

The Nantes Saint-Nazaire metro area is famous for its health and biotechnology research, supported by the "competitiveness cluster" accreditation obtained by Atlanpole Biotherapies in 2005. The presence of key infrastructure facilities, such as the Arronax cyclotron, innovative SMEs and research institutes have helped build this well-deserved reputation.

Atlanpole Biotherapies, superior appeal

Atlanpole Biotherapies is one of the most economically attractive and dynamic clusters for the development of biotherapeutics in France. It boasts the highest number of projects funded in France, attracts a large number of researchers - one thousand over the last decade - and promotes the emergence of start-ups.

Radiopharmaceuticals: the only hub in France

Isotop4life is the leading French consortium that brings together the industrial and academic communities to innovate in the field of radiopharmaceuticals. It pools and coordinates resources and stakeholders concerned by the use of radioisotopes for health.

Arronax promotes research, treatments and diagnostics

Arronax – Accelerator for Research in Radiochemistry and Oncology at Nantes Atlantique – manages the Arronax cyclotron, a world-class particle accelerator dedicated to the production of radioisotopes. Its applications include medical imaging, radiation therapy, as well as research (nuclear medicine, nuclear physics and nuclear chemistry).

News

Startups: Record financing in Nantes in 2017

Published on 16/03/2018
Business, Digital, Health / Biotech, Talents

E-health: 10 startups move into the Creative Care Factory on the Ile de Nantes

Published on 16/05/2017
Health / Biotech, Real estate, Attractiveness

Biotechnology: Nantes firms at the BIO2015 International Convention in Philadelphia

Published on 17/06/2015
Health / Biotech

See all news

Events

NAT - EDITION 2018

From 31 May to 01 June 2018
Nantes

CONGRES DE LA SOCIETE FRANCAISE DE CHIRURGIE RACHIDIENNE - SFCR

From 07 to 09 June 2018
Nantes

19EMES JOURNEES NATIONALES D'INFECTIOLOGIE (JNI)

From 13 to 15 June 2018
Nantes

See all events

A networking mindset and transdisciplinary collaboration across all local stakeholders make the Nantes healthcare sector a national or global leader in several specialties. Start-ups are continually being created in this sector, doubling in number in the last decade.

On the cutting edge in three fields

Biotherapeutics are a priority for economic development in Nantes Saint-Nazaire. Atlanpole Biotherapies, an interregional competitiveness cluster, brings together over 80 companies working in the life sciences and health. Some are European or world leaders in their respective fields, like Eurofins (bio-analysis) Valneva (vaccines against emerging infectious diseases) and Biomérieux. It brings together 51 laboratories and 42 technology platforms. The research focuses on three main themes: immunotherapy, radiopharmaceuticals and regenerative medicine.

A magnet hospital for transplants

Nantes University Hospital has a unit dedicated to heart and lung transplants, and ranks second in France for this specialty. It also has the Urology and Nephrology Transplant Institute, a leading European transplant centre for kidney and pancreas transplants. The Institute also formed the European Centre for Transplantation and Immunotherapy Sciences (CESTI), which holds some twenty patents and licenses.

The "Hospital of the Future" in a healthcare district

Nantes Hospital will be moving to the Ile de Nantes in 2023-2026, creating new opportunities for the sector. The project calls for a fully connected, high-tech hospital located at the heart of a university hospital campus, with 6,000 students and faculty, putting Nantes well on track to building the Hospital of the Future. The Nantes Biotech building, adjoining the new Health Research Institute (by 2020), is already home to biotechnology companies.

Creative Care Factory

Digisanté, Pulsio Santé, Mobidys, Atmotrack, Directosante, Wello, Team Officine, My Welper, Benevolt and Recipro-cite are among the dozen or so innovative companies in the field of health,well-being and better living that have taken up quarters in the Creative Care Factory at the headquarters of Harmonie Mutuelle, in the Creative Factory.

Key figures

research laboratories and 42 technology platforms with more than 1,000 researchers in the life sciences.

companies are present at Atlanpole Biotherapies.

1 billion

euros will be invested to build the future University Hospital on the Ile de Nantes.

Immunotherapy

There are more than 60 institutions, research labs and healthcare units, businesses, technology platforms and hospital facilities in this field focusing on research and innovation on antibodies, vaccines against cancer and autoimmune and infectious diseases.

Radiopharmaceuticals

Under the banner "Isotop4Life", some forty institutions in Pays de la Loire as well as the Brittany and Centre regions are working together on several group projects.

Regenerative medicine

The members of Atlanpole Biotherapies develop innovative solutions to address the shortage of organs, as well as solutions for immunological care for transplant patients. They are experimenting with new therapeutic approaches for bone and joint diseases, dermatology, oncology, pulmonology and rare diseases.

E-health

A dozen or so innovative companies in the field of health,well-being and better living have taken up quarters on the same floor at the headquarters of Harmonie Mutuelle, in the Creative Factory. The University of Nantes won the "E-Health trophy 2016" for Noa, an assistive robot developed to improve compliance of asthmatic children in taking their long-term control medications.

Hybrid technologies

Businesses and research organizations work together at the interregional level, in sectors such as electronics and materials, providing the biomarkers, vectors, medical devices, instrumentation, experimental models, processes and software solutions needed to support the therapeutic innovations developed at Atlanpole Biotherapies.